blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3797766

EP3797766 - COMPOSITIONS FOR USE IN REDUCING INFLAMMATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.02.2022
Database last updated on 19.10.2024
FormerRequest for examination was made
Status updated on  21.05.2021
FormerThe application has been published
Status updated on  26.02.2021
Most recent event   Tooltip04.02.2022Application deemed to be withdrawnpublished on 09.03.2022  [2022/10]
Applicant(s)For all designated states
Evonik Operations GmbH
Rellinghauser Straße 1-11
45128 Essen / DE
[2021/13]
Inventor(s)01 / ZETTL, Lisa.
Kasinostrasse 1
64293 Darmstadt / DE
02 / HEADLEY, Laura.
Am Stettbach 4A
64367 Mühltal / DE
03 / ENGEL, Andrea.
Am Henninger Turm 16
60599 Frankfurt / DE
04 / BENEDIKT, Anne.
Ginnheimer Hohl 18
60431 Frankfurt / DE
05 / KUHN, Ann-Katrin.
Viktoriaplatz 2
64293 Darmstadt / DE
 [2021/13]
Representative(s)Evonik Patent Association
c/o Evonik Industries AG
IP Management
Bau 1042A/PB 15
Paul-Baumann-Straße 1
45772 Marl / DE
[2021/13]
Application number, filing date19199203.124.09.2019
[2021/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3797766
Date:31.03.2021
Language:EN
[2021/13]
Search report(s)(Supplementary) European search report - dispatched on:EP07.04.2020
ClassificationIPC:A61K31/19, A61P29/00
[2021/13]
CPC:
A61K31/19 (EP,US); A61P29/00 (EP); C12N5/0645 (US);
C12N2500/14 (US); C12N2500/32 (US)
C-Set:
A61K31/19, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/25]
Former [2021/13]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ZUSAMMENSETZUNGEN ZUR VERWENDUNG BEI DER REDUZIERUNG VON ENTZÜNDUNGEN[2021/13]
English:COMPOSITIONS FOR USE IN REDUCING INFLAMMATION[2021/13]
French:COMPOSITIONS À UTILISER POUR RÉDUIRE L'INFLAMMATION[2021/13]
Examination procedure18.05.2021Examination requested  [2021/25]
18.05.2021Date on which the examining division has become responsible
01.10.2021Application deemed to be withdrawn, date of legal effect  [2022/10]
21.10.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time  [2022/10]
Fees paidRenewal fee
22.09.2021Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US4363815  (YU RUEY J, et al) [X] 1,10* pages 16-30, column 7; claim 5 *;
 [X]WO9710818  (CELLULAR SCIENCES INC [US], et al) [X] 1,4,5,10-12 * page 13, paragraph 5; example 1; claims 1,5,6,14 *;
 [X]WO02074301  (UNIV PITTSBURGH [US], et al) [X] 1,8,10-12 * examples II,VI; claims 1,5,6,10,23,25,27 *;
 [XI]US2005197397  (MARTIN ALAIN [US]) [X] 1,2,4-12 * paragraphs [0022] , [0089] , [0091] , [0095] , [0097] , [0249] , [0246]; claims 1,3-5,7,8 * [I] 2,3
by applicantUS4100161
 US4677121
 US6100287
 WO2008122473
 WO2010112362
    - WU et al., PLoS One, (20170000), vol. 12, page 5
    - WALSER, M. et al., Kidney International, (19900000), vol. 38, pages 595 - 604
    - MU et al., nutrients, (20180000), vol. 10, page 918
    - ZHENYUKH et al., J Cell Mol Med., (20180000), vol. 22, pages 4948 - 4962
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.